-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Gaucher Disease

Program: Education Program
Session: Anxiety Provoking Hematology Consults, Second Edition
Saturday, December 5, 2020, 11:55 AM-12:00 PM

Ari Zimran, MD

Shaare Zedek Medical Center, Gaucher Unit, Jerusalem, Israel

Disclosures: Zimran: Centogene: Research Funding; BioEvents: Honoraria; Pfizer: Honoraria, Research Funding; Prevail Therapeutics: Consultancy; Takeda Pharmaceutical: Consultancy, Honoraria, Research Funding, Speakers Bureau.

OffLabel Disclosure: I will mention chaperone therapy like high-dose ambroxol (off label) and gene therapy (both in-vivo and ex-vivo) which is in phase 1/2 clinical trial.

See more of: Anxiety Provoking Hematology Consults, Second Edition
See more of: Education Program
<< Previous Presentation | Next Presentation